Up 22% in 3 months! Ought to traders take into account shopping for shares on this FTSE 100 pharma big?
By
Admin
A 67% forecast annual earnings progress however down 19%, is that this FTSE 250 defence inventory an important short-term danger/long-term reward play?
By
Admin
